LEUKOCARE

OverviewSuggest Edit

LEUKOCARE is a provider of technologies for biological functionalization of medical devices, as well as the stabilization and protection of proteins and biological molecules in biopharmaceutical formulations. Its proprietary stabilizing and protecting solutions (SPS) platform aims to increase the stability and protection of therapeutic proteins in dry and liquid formulations.
TypePrivate
Founded2003
HQPlanegg, DE
Websiteleukocare.com

Latest Updates

Employees (est.) (Sept 2021)49(+9%)
Cybersecurity ratingBMore

LEUKOCARE Office Locations

LEUKOCARE has an office in Planegg
Planegg, DE (HQ)
Innovations- und Gründerzentrum Biotechnologie (IZB), Am Klopferspitz 19
Show all (1)

LEUKOCARE Financials and Metrics

Summary Metrics

Founding Date

2003

LEUKOCARE total Funding

$17.5 m

LEUKOCARE latest funding size

$17.5 m

Time since last funding

3 months ago

LEUKOCARE investors

LEUKOCARE's latest funding round in June 2021 was reported to be $17.5 m. In total, LEUKOCARE has raised $17.5 m
Show all financial metrics

LEUKOCARE Cybersecurity Score

Cybersecurity ratingPremium dataset

B

86/100

SecurityScorecard logo

LEUKOCARE Online and Social Media Presence

Embed Graph

LEUKOCARE News and Updates

Leukocare Announces USD 17.5 Million Financing Round to Further Expand US Business and Bioinformatics Activities

MARTINSRIED, Germany and MUNICH, Germany and MILFORD, Mass., June 23, 2021 (GLOBE NEWSWIRE) -- Leukocare AG, a biotechnology company specialized in the field of biopharmaceutical formulation development, today announced the closing of a USD 17.5 million (EUR 14.6 million) financing, led by Petrich…

Rentschler Biopharma and Leukocare extend service offering with joint U.S. site

LAUPHEIM, Germany and MARTINSRIED, Germany, and MILFORD, Mass., March 22, 2021 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, and Leukocare AG, a German biotechnology company specialized in the field …

Leukocare starts operations in the US and opens development laboratories and offices in Boston Metropolitan Area

MARTINSRIED, Germany and MUNICH, Germany and MILFORD, Mass., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Leukocare AG, a German biotechnology company specialized in formulation development for biologics, viral vectors and vaccines, today announced the opening of its development laboratories and offices in …

LEUKOCARE Frequently Asked Questions

  • When was LEUKOCARE founded?

    LEUKOCARE was founded in 2003.

  • How many employees does LEUKOCARE have?

    LEUKOCARE has 49 employees.

  • Who are LEUKOCARE competitors?

    Competitors of LEUKOCARE include Crescendo Biologics, Spiderwort and Western Oncolytics.

  • Where is LEUKOCARE headquarters?

    LEUKOCARE headquarters is located at Innovations- und Gründerzentrum Biotechnologie (IZB), Am Klopferspitz 19, Planegg.

  • Where are LEUKOCARE offices?

    LEUKOCARE has an office in Planegg.

  • How many offices does LEUKOCARE have?

    LEUKOCARE has 1 office.